These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34927353)

  • 1. A Novel Imidazolinone Derivative with 5-Arylidene and 2-Substituted Mercapto Group as Potent Anti-Hepatitis C Virus Compound.
    Kong Y; Mao C; Li S; Xie Y; Zhang XL; Fu B
    Chem Biodivers; 2022 Feb; 19(2):e202100602. PubMed ID: 34927353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of indole derivatives as novel hepatitis C virus inhibitors.
    Han Z; Liang X; Wang Y; Qing J; Cao L; Shang L; Yin Z
    Eur J Med Chem; 2016 Jun; 116():147-155. PubMed ID: 27061978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors.
    Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Yueh A; Wang JC; Hsu TA; Chao YS; Chern JH
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6063-8. PubMed ID: 19796940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors.
    He S; Jain P; Lin B; Ferrer M; Hu Z; Southall N; Hu X; Zheng W; Neuenswander B; Cho CH; Chen Y; Worlikar SA; Aubé J; Larock RC; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
    ACS Comb Sci; 2015 Oct; 17(10):641-52. PubMed ID: 26332742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Çakir G; Küçükgüzel İ; Guhamazumder R; Tatar E; Manvar D; Basu A; Patel BA; Zia J; Talele TT; Kaushik-Basu N
    Arch Pharm (Weinheim); 2015 Jan; 348(1):10-22. PubMed ID: 25449674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.
    Hassan GS; Georgey HH; Mohammed EZ; Omar FA
    Eur J Med Chem; 2019 Dec; 184():111747. PubMed ID: 31604164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
    Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
    Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 3-Amino-2-Hydroxypropoxyisoflavone Derivatives as Potential Anti-HCV Agents.
    Lee JC; Lin CK; Tseng CK; Chen YL; Tzeng CC; Tseng CH
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses.
    Peng HK; Chen WC; Lee JC; Yang SY; Tzeng CC; Lin YT; Yang SC
    Org Biomol Chem; 2013 Mar; 11(11):1858-66. PubMed ID: 23377187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.
    Manfroni G; Manvar D; Barreca ML; Kaushik-Basu N; Leyssen P; Paeshuyse J; Cannalire R; Iraci N; Basu A; Chudaev M; Zamperini C; Dreassi E; Sabatini S; Tabarrini O; Neyts J; Cecchetti V
    J Med Chem; 2014 Apr; 57(8):3247-62. PubMed ID: 24654886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
    Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus.
    Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK
    Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and In Vitro anti-HCV and Antitumor Evaluation of Schisandronic Acid Derivatives.
    Zhang KX; Qian XJ; Zheng W; Cai MC; Ma Y; Zhang DZ; Yu SC; Meng QG; Jin YS
    Med Chem; 2021; 17(9):974-982. PubMed ID: 32819233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
    PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors.
    Kang IJ; Wang LW; Yeh TK; Lee CC; Lee YC; Hsu SJ; Wu YS; Wang JC; Chao YS; Yueh A; Chern JH
    Bioorg Med Chem; 2010 Sep; 18(17):6414-21. PubMed ID: 20675142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of naphtho[1,2-d]oxazole derivatives as potential anti-HCV agents through inducing heme oxygenase-1 expression.
    Tseng CH; Lin CK; Chen YL; Tseng CK; Lee JY; Lee JC
    Eur J Med Chem; 2018 Jan; 143():970-982. PubMed ID: 29232587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression.
    Nguyen BN; Okuno Y; Ajiro M; Iida K; Denawa M; Yamamoto M; Sakamoto N; Kagechika H; Hagiwara M
    J Med Virol; 2017 Jul; 89(7):1224-1234. PubMed ID: 27922182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and anti-HCV activity of thiourea compounds.
    Kang IJ; Wang LW; Lee CC; Lee YC; Chao YS; Hsu TA; Chern JH
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1950-5. PubMed ID: 19251415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
    Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
    J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based optimization and derivatization of 2-substituted quinolone-based non-nucleoside HCV NS5B inhibitors with submicromolar cellular replicon potency.
    Cheng Y; Shen J; Peng RZ; Wang GF; Zuo JP; Long YQ
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2900-2906. PubMed ID: 27133482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.